The minimal clinically important difference has been reported to be 18 points.9 Those included were females and males aged 18 years or higher with
SPADI a$?18 points who gave written informed consent.
In our study, the
SPADI questionnaire was completed by all patients, which synchronously assess pain and functionality (11).
There is no significant difference between the pre-treatment
SPADI scores of Group A and Group B.
Disability measured using the
SPADI was significantly decreased.
The
SPADI is a 100-point, 13-item, self-administered questionnaire, divided into 2 subscales: a 5-item pain subscale and an 8-item disability subscale.
Indipendentemente dal gruppo di trattamento, i pazienti che hanno ricevuto un trattamento aggiuntivo hanno riportato un valore medio alla
SPADI superiore agli altri sia all'inizio (52[+ or -]20) che ad 1 anno di follow-up (40,4[+ or -]25).
Shoulder disability on
SPADI Scale decreased to 56.43 from 78.43.
Function was assessed by using the Shoulder Pain and Disability Index (
SPADI).
The outcome was measured using the Shoulder Pain and Disability Index (
SPADI) and the results were significant after 15 treatments with a decrease in
SPADI of 44 points, a measure that was still present at 6 months after the conclusion of the treatments.
(106) Fabio
Spadi, The Bridge on the Strait of Messina: "'Lowering'" the Right of Innocent Passage?, 50 INT'L & COMP.
At 22 weeks, the active group demonstrated a statistically significant advantage compared with the placebo group in one primary measure; the Shoulder Pain and Disability Index (
SPADI).